STEAG microParts acquired by German partner

Sept. 20, 2004 – STEAG microParts’ leading customer and a co-developer is acquiring the Dortmund, Germany-based subsidiary of STEAG AG.

German pharmaceutical firm Boehringer Ingelheim plans to take control of STEAG microParts by Oct. 1. It will become a legally independent company known as Boehringer Ingelheim microParts GmbH, according to company news releases.

Boehringer Ingelheim officials said the acquisition fits well within its production strategy, especially related to Respimat, the aerosol inhaler jointly developed by the companies. The metered-dose inhaler, sold by Boehringer, processes liquid through a micronozzle and delivers precise doses of drugs without environmentally harmful propellant gases.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.